Willemien Van Driel

10PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsClimate change science not elsewhere classifiedImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 19, 2025
Budget Impact Analysis of Hyperthermic Intraperitoneal Chemotherapy With Interval Cytoreductive Surgery in Ovarian Cancer.

Madelief Schreuder Goedheijt, Ruby M van Stein, Simone N Koole

|Apr 14, 2025
Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial.

S L Aronson, B Thijssen, M Lopez-Yurda

|Jan 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.

Stéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong

|Oct 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.

Janice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson

|Oct 01, 2024
Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy.

Sarah E Ferguson, Lori A Brotto, Janice Kwon

|Jun 12, 2024
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1).

S Lot Aronson, Cédric Walker, Bram Thijssen

Pageof 2

Frequent Collaborators

5 joint publications

Gabe Sonke

3 joint publications

S Lot Aronson

2 joint publications

Simone N Koole

2 joint publications

Bram Thijssen